v3.25.4
Borrowings - SPV III Credit Facility (Details) - USD ($)
$ in Thousands
 12 Months Ended
Mar. 28, 2024
Dec. 31, 2025
Mar. 07, 2025
Dec. 31, 2024
Borrowings        
Fair value   $ 5,819,755 [1],[2]   $ 4,008,973 [3],[4]
SPV III Credit Facility        
Borrowings        
Maximum borrowing capacity $ 100,000   $ 200,000  
Debt instrument, accordion feature facility $ 250,000      
Line of credit facility, maximum borrowing capacity, percentage 70.00%      
Weighted average interest rate   5.70%   7.30%
SPV III Credit Facility | Credit Facility Through September 5, 2024        
Borrowings        
Commitment fee (in percent)   0.75%    
SPV III Credit Facility | Credit Facility After September 5, 2024        
Borrowings        
Commitment fee (in percent)   0.50%    
SPV III Credit Facility | Margin Rate        
Borrowings        
Interest rate, basis spread   1.95%    
SPV III Credit Facility | Minimum | Adjusted Term SOFR        
Borrowings        
Interest rate, basis spread   1.00%    
SPV III Credit Facility | Asset pledged as collateral        
Borrowings        
Fair value   $ 266,769   $ 142,151
[1] All of the Company’s investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, as amended, (the “1940 Act”), unless otherwise noted. All of the Company’s investments are issued by U.S. portfolio companies unless otherwise noted.
[2] Except as otherwise noted, because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Valuation Designee. (See Note 4 in the accompanying notes to the consolidated financial statements).
[3] All of the Company’s investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, as amended, (the “1940 Act”), unless otherwise noted. All of the Company’s investments are issued by U.S. portfolio companies unless otherwise noted.
[4] Except as otherwise noted, because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Valuation Designee. (See Note 4 in the accompanying notes to the consolidated financial statements).